Association of chronic cough and pulmonary function with 6-minute walk test performance in HIV infection.
Association of chronic cough and pulmonary function with 6-minute walk test performance in HIV infection.
复制标题
HIV 感染者慢性咳嗽和肺功能与 6 分钟步行测试表现的关系。
DOI:
10.1097/qai.0000000000000086
复制
发表时间:
2014-04-15
期刊:
影响因子:
--
通讯作者:
Crothers K
中科院分区:
文献类型:
--
作者:
Campo M;Oursler KK;Huang L;Goetz MB;Rimland D;Hoo GS;Brown ST;Rodriguez-Barradas MC;Au D;Akgün KM;Shahrir S;Crothers K
Chronic lung disease has been associated with greater impairment in self-reported physical function in HIV patients. We sought to study this association using objective measures of physical or pulmonary function. Baseline data from the Examinations of HIV Associated Lung Emphysema (EXHALE) study, a multicenter observational cohort of HIV-infected and uninfected Veterans. We assessed the association between clinical, laboratory, and pulmonary function measures on six-minute walk test (6-MWT). Multivariable linear regression models were generated to identify factors associated with 6-MWT performance. 340 participants completed 6-MWT (mean age 55 years), with 68% black race, 94% men and 62% current smokers. Overall, 180 (53%) were HIV-infected and 63 (19%) had spirometry-defined COPD. In a multivariable model, age, current smoking, and obesity (BMI>30) were independently associated with lower 6-MWT performance, but HIV infection was not; there was a significant interaction between HIV and chronic cough, such that distance walked among HIV-infected participants with chronic cough was 51.76 meters less (p=0.04) compared to those without cough or HIV. Among HIV-infected participants, the forced expiratory volume in one second (FEV1, % predicted), to a greater extent than total lung capacity or diffusion capacity, attenuated the association with chronic cough; decreased FEV1 was independently associated with lower 6-MWT performance in those with HIV. Older age, current smoking and airflow limitation were important determinants of 6-MWT performance in the HIV-infected participants. These findings suggest potential interventions to improve physical function may include early management of respiratory symptoms and airflow limitation.